Edwards Lifesciences Corp Stock Price History
EW Stock | USD 85.94 0.51 0.59% |
Below is the normalized historical share price chart for Edwards Lifesciences Corp extending back to March 27, 2000. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Edwards Lifesciences stands at 85.94, as last reported on the 19th of April, with the highest price reaching 87.20 and the lowest price hitting 85.38 during the day.
If you're considering investing in Edwards Stock, it is important to understand the factors that can impact its price. Edwards Lifesciences appears to be very steady, given 3 months investment horizon. Edwards Lifesciences Corp secures Sharpe Ratio (or Efficiency) of 0.12, which denotes the company had a 0.12% return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for Edwards Lifesciences Corp, which you can use to evaluate the volatility of the firm. Please utilize Edwards Lifesciences' Mean Deviation of 1.38, downside deviation of 1.33, and Coefficient Of Variation of 796.11 to check if our risk estimates are consistent with your expectations.
At this time, Edwards Lifesciences' Total Stockholder Equity is fairly stable compared to the past year. Liabilities And Stockholders Equity is likely to climb to about 9.8 B in 2024, despite the fact that Other Stockholder Equity is likely to grow to (2.6 B). . At this time, Edwards Lifesciences' Price To Operating Cash Flows Ratio is fairly stable compared to the past year. Price To Free Cash Flows Ratio is likely to climb to 77.16 in 2024, whereas Price Earnings Ratio is likely to drop 31.34 in 2024. Edwards Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 27th of March 2000 | 200 Day MA 78.7798 | 50 Day MA 89.947 | Beta 1.074 |
Edwards |
Sharpe Ratio = 0.1178
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | EW | |||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns |
Estimated Market Risk
2.1 actual daily | 18 82% of assets are more volatile |
Expected Return
0.25 actual daily | 4 96% of assets have higher returns |
Risk-Adjusted Return
0.12 actual daily | 9 91% of assets perform better |
Based on monthly moving average Edwards Lifesciences is performing at about 9% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Edwards Lifesciences by adding it to a well-diversified portfolio.
Price Book 8.1717 | Enterprise Value Ebitda 30.3262 | Price Sales 9.0498 | Shares Float 595.3 M | Wall Street Target Price 94.28 |
Edwards Lifesciences Stock Price History Chart
There are several ways to analyze Edwards Stock price data. The simplest method is using a basic Edwards candlestick price chart, which shows Edwards Lifesciences price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | March 28, 2024 | 95.56 |
Lowest Price | January 24, 2024 | 72.54 |
Edwards Lifesciences April 19, 2024 Stock Price Synopsis
Various analyses of Edwards Lifesciences' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Edwards Stock. It can be used to describe the percentage change in the price of Edwards Lifesciences from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Edwards Stock.Edwards Lifesciences Price Daily Balance Of Power | (0.28) | |
Edwards Lifesciences Price Action Indicator | (0.61) | |
Edwards Lifesciences Price Rate Of Daily Change | 0.99 | |
Edwards Lifesciences Accumulation Distribution | 81,309 |
Edwards Lifesciences April 19, 2024 Stock Price Analysis
Edwards Stock Price History Data
The price series of Edwards Lifesciences for the period between Sat, Jan 20, 2024 and Fri, Apr 19, 2024 has a statistical range of 23.02 with a coefficient of variation of 7.82. Under current investment horizon, the daily prices are spread out with arithmetic mean of 86.81. The median price for the last 90 days is 87.24. The company completed 3:1 stock split on 1st of June 2020.Open | High | Low | Close | Volume | ||
04/19/2024 | 87.20 | 87.20 | 85.38 | 85.94 | 3,895,701 | |
04/18/2024 | 87.35 | 87.35 | 85.98 | 86.45 | 3,122,037 | |
04/17/2024 | 89.89 | 89.89 | 86.45 | 87.24 | 2,878,118 | |
04/16/2024 | 89.09 | 90.40 | 87.87 | 90.05 | 2,640,500 | |
04/15/2024 | 91.35 | 91.73 | 88.96 | 89.20 | 2,863,151 | |
04/12/2024 | 90.78 | 90.78 | 89.38 | 90.28 | 3,155,519 | |
04/11/2024 | 92.83 | 92.99 | 91.02 | 91.41 | 2,453,586 | |
04/10/2024 | 91.73 | 91.89 | 90.81 | 91.51 | 2,836,384 | |
04/09/2024 | 92.34 | 93.11 | 91.17 | 93.05 | 2,633,591 | |
04/08/2024 | 92.61 | 92.86 | 91.57 | 92.34 | 2,667,004 | |
04/05/2024 | 91.40 | 92.93 | 90.86 | 92.70 | 2,563,320 | |
04/04/2024 | 93.68 | 94.37 | 91.11 | 91.20 | 3,929,048 | |
04/03/2024 | 93.95 | 95.07 | 92.77 | 93.02 | 3,189,401 | |
04/02/2024 | 93.45 | 94.41 | 92.37 | 94.31 | 2,727,538 | |
04/01/2024 | 95.73 | 95.73 | 93.27 | 94.25 | 3,506,287 | |
03/28/2024 | 95.48 | 96.12 | 94.87 | 95.56 | 4,007,471 | |
03/27/2024 | 93.75 | 95.35 | 93.59 | 95.15 | 3,656,854 | |
03/26/2024 | 93.47 | 94.33 | 93.22 | 93.42 | 2,750,083 | |
03/25/2024 | 93.93 | 94.50 | 92.96 | 93.16 | 2,497,207 | |
03/22/2024 | 94.46 | 95.08 | 93.20 | 93.79 | 2,452,594 | |
03/21/2024 | 93.90 | 95.18 | 93.88 | 94.68 | 3,731,873 | |
03/20/2024 | 94.26 | 94.40 | 91.98 | 93.04 | 3,385,224 | |
03/19/2024 | 93.14 | 94.44 | 92.32 | 94.31 | 3,893,516 | |
03/18/2024 | 92.48 | 93.04 | 91.95 | 92.85 | 2,899,680 | |
03/15/2024 | 92.46 | 94.00 | 92.16 | 92.31 | 5,700,263 | |
03/14/2024 | 93.03 | 95.27 | 92.47 | 93.36 | 5,066,433 | |
03/13/2024 | 90.91 | 93.30 | 90.09 | 92.93 | 7,036,488 | |
03/12/2024 | 90.58 | 91.15 | 89.79 | 90.91 | 2,323,869 | |
03/11/2024 | 91.73 | 92.04 | 90.70 | 90.83 | 2,974,007 | |
03/08/2024 | 93.34 | 94.21 | 91.91 | 92.14 | 5,909,396 | |
03/07/2024 | 90.98 | 93.89 | 90.74 | 93.81 | 6,846,240 | |
03/06/2024 | 86.43 | 88.65 | 86.28 | 88.33 | 3,552,002 | |
03/05/2024 | 86.79 | 87.40 | 85.66 | 86.10 | 2,226,179 | |
03/04/2024 | 85.36 | 87.59 | 85.32 | 87.02 | 6,772,229 | |
03/01/2024 | 84.40 | 85.74 | 83.61 | 85.22 | 3,296,234 | |
02/29/2024 | 86.00 | 86.03 | 84.43 | 84.87 | 5,175,056 | |
02/28/2024 | 86.32 | 86.62 | 85.48 | 86.00 | 2,635,365 | |
02/27/2024 | 86.12 | 86.72 | 85.41 | 86.51 | 4,069,694 | |
02/26/2024 | 87.39 | 87.73 | 85.84 | 86.15 | 6,365,932 | |
02/23/2024 | 87.92 | 88.33 | 87.37 | 87.74 | 2,797,857 | |
02/22/2024 | 86.36 | 87.76 | 85.49 | 87.62 | 2,460,753 | |
02/21/2024 | 87.02 | 87.16 | 86.20 | 86.65 | 2,142,405 | |
02/20/2024 | 85.80 | 87.00 | 85.30 | 86.90 | 3,235,519 | |
02/16/2024 | 85.84 | 87.25 | 85.43 | 86.10 | 2,122,108 | |
02/15/2024 | 86.30 | 86.71 | 85.38 | 86.04 | 2,727,304 | |
02/14/2024 | 86.62 | 87.28 | 85.03 | 86.04 | 4,976,605 | |
02/13/2024 | 86.00 | 87.48 | 85.31 | 86.26 | 4,012,986 | |
02/12/2024 | 84.83 | 87.47 | 84.44 | 87.12 | 3,826,096 | |
02/09/2024 | 86.08 | 86.69 | 84.89 | 85.01 | 3,052,114 | |
02/08/2024 | 86.45 | 86.65 | 85.21 | 85.80 | 3,723,135 | |
02/07/2024 | 89.44 | 89.44 | 82.53 | 86.61 | 7,386,806 | |
02/06/2024 | 86.13 | 88.83 | 85.00 | 88.25 | 7,192,516 | |
02/05/2024 | 88.00 | 90.20 | 85.99 | 86.06 | 10,824,517 | |
02/02/2024 | 80.00 | 86.47 | 79.72 | 86.09 | 11,802,534 | |
02/01/2024 | 78.29 | 78.91 | 77.11 | 78.71 | 5,020,840 | |
01/31/2024 | 77.76 | 79.93 | 77.19 | 78.47 | 9,470,520 | |
01/30/2024 | 74.36 | 74.48 | 73.68 | 73.90 | 2,118,650 | |
01/29/2024 | 72.98 | 74.62 | 72.71 | 74.57 | 2,683,396 | |
01/26/2024 | 73.55 | 73.81 | 72.97 | 73.24 | 2,812,100 | |
01/25/2024 | 73.33 | 73.78 | 71.92 | 73.55 | 4,588,509 | |
01/24/2024 | 75.16 | 75.19 | 72.47 | 72.54 | 4,094,867 |
About Edwards Lifesciences Stock history
Edwards Lifesciences investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Edwards is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Edwards Lifesciences Corp will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Edwards Lifesciences stock prices may prove useful in developing a viable investing in Edwards Lifesciences
Last Reported | Projected for Next Year | ||
Common Stock Shares Outstanding | 609.4 M | 550.8 M | |
Net Income Applicable To Common Shares | 1.8 B | 1.8 B |
Edwards Lifesciences Quarterly Net Working Capital |
|
Edwards Lifesciences Stock Technical Analysis
Edwards Lifesciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Technical Analysis Now
Technical AnalysisCheck basic technical indicators and analysis based on most latest market data |
All Next | Launch Module |
Edwards Lifesciences Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Edwards Lifesciences' price direction in advance. Along with the technical and fundamental analysis of Edwards Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Edwards to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | 0.0846 | |||
Jensen Alpha | 0.2015 | |||
Total Risk Alpha | 0.0528 | |||
Sortino Ratio | 0.1404 | |||
Treynor Ratio | 0.3238 |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Edwards Lifesciences Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in housing. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Complementary Tools for Edwards Stock analysis
When running Edwards Lifesciences' price analysis, check to measure Edwards Lifesciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Edwards Lifesciences is operating at the current time. Most of Edwards Lifesciences' value examination focuses on studying past and present price action to predict the probability of Edwards Lifesciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Edwards Lifesciences' price. Additionally, you may evaluate how the addition of Edwards Lifesciences to your portfolios can decrease your overall portfolio volatility.
Transaction History View history of all your transactions and understand their impact on performance | |
AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |
Is Edwards Lifesciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Edwards Lifesciences. If investors know Edwards will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Edwards Lifesciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.06) | Earnings Share 2.3 | Revenue Per Share 9.897 | Quarterly Revenue Growth 0.138 | Return On Assets 0.1225 |
The market value of Edwards Lifesciences Corp is measured differently than its book value, which is the value of Edwards that is recorded on the company's balance sheet. Investors also form their own opinion of Edwards Lifesciences' value that differs from its market value or its book value, called intrinsic value, which is Edwards Lifesciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Edwards Lifesciences' market value can be influenced by many factors that don't directly affect Edwards Lifesciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Edwards Lifesciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Edwards Lifesciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Edwards Lifesciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.